Sign Up to like & get
recommendations!
1
Published in 2020 at "Molecular cell"
DOI: 10.1016/j.molcel.2020.09.028
Abstract: Diffuse midline gliomas and posterior fossa type A ependymomas contain the recurrent histone H3 lysine 27 (H3 K27M) mutation and express the H3 K27M-mimic EZHIP (CXorf67), respectively. H3 K27M and EZHIP are competitive inhibitors of…
read more here.
Keywords:
ezhip impede;
k27m ezhip;
prc2;
impede h3k27 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaa222.173
Abstract: Abstract BACKGROUND Gene expression and DNA methylation have identified 2 distinct clinicopathological subgroups among the WHO Grade II/III posterior fossa (PF) ependymomas (EPN), of which the PF-A molecular subgroup associates with poor outcome. OBJECTIVE To…
read more here.
Keywords:
ezh2;
h3k27me3;
expression;
h3k27me3 loss ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.abc0497
Abstract: Description Childhood posterior fossa group A ependymomas demonstrate integrated metabolic and epigenetic pathways that can be disrupted by metformin. Understanding childhood ependymomas Children with posterior fossa group A (PFA) ependymomas have a dismal prognosis. PFAs…
read more here.
Keywords:
childhood;
tca cycle;
cycle metabolism;
ezhip ... See more keywords